Morgan Cheatham is a vice president in the New York City office where he focuses on investments in healthcare and life sciences from early to growth stages. He has a particular interest in companies leveraging unique datasets and computational methods to improve patient care from bench to bedside. Morgan works closely with a number of portfolio companies including serving on the board of FOLX Health.
Before joining Bessemer, Morgan worked at Goldman Sachs in the Consumer Retail and Healthcare Group in the Investment Banking Division. Prior to investment banking, he was a data scientist at Kyruus, a healthcare IT startup focused on patient access and provider data management.
Morgan is pursuing his medical degree at The Warren Alpert Medical School of Brown University and graduated magna cum laude from Brown University with a B.S. in neuroeconomics. You can follow his latest thinking on Twitter @morgancheatham.